Gentamicin improves the activities of daptomycin and vancomycin against Enterococcus faecalis in vitro and in an

Ulrika Furustrand Tafin1, Ivana Majic, Cyrine Zalila Belkhodja

  • 1Infectious Diseases Service, Department of Medicine, University Hospital and University of Lausanne, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland.

Insights

Daptomycin showed better activity than vancomycin against enterococcal implant infections. Combining daptomycin or vancomycin with gentamicin improved cure rates in an animal model, though eradication remains challenging.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Enterococcal implant-associated infections lack defined optimal treatment regimens.
  • Enterococcus faecalis is a common pathogen in these difficult-to-treat infections.
  • Evaluating antibiotic efficacy against adherent bacteria is crucial for treatment strategies.

Purpose of the Study:

  • To investigate the in vitro and in vivo activity of daptomycin, vancomycin, and gentamicin against Enterococcus faecalis.
  • To assess the efficacy of antibiotic combinations in a foreign-body infection model.
  • To determine optimal treatment strategies for enterococcal implant-associated infections.

Main Methods:

  • In vitro studies included time-kill assays and microcalorimetry.
  • A guinea pig foreign-body infection model with subcutaneously implanted cages was utilized.
  • Antibiotic treatment (daptomycin, vancomycin, gentamicin, and combinations) was administered for 4 days, starting 3 hours post-infection.

Main Results:

  • Daptomycin demonstrated greater activity than vancomycin against adherent E. faecalis in vitro.
  • Gentamicin, even at subinhibitory concentrations, enhanced the activity of daptomycin and vancomycin in vitro.
  • In the animal model, daptomycin achieved a 55% cure rate when combined with gentamicin, compared to 25% for daptomycin alone. Vancomycin with gentamicin achieved 33% versus 17% alone.

Conclusions:

  • Daptomycin is more effective than vancomycin against adherent E. faecalis, with synergistic improvement observed when combined with gentamicin.
  • The combination of daptomycin and gentamicin offers the highest cure rate (55%) in this early-stage implant infection model.
  • Eradicating E. faecalis from implants, even in the early stages, remains a significant clinical challenge, necessitating further research into treatment optimization.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...